As of late May 2026, the numbers are locked in: the average Medicare beneficiary will pay roughly $240 more this year than they did in 2025 before they ever walk into a doctor’s office. Part B premiums have climbed to $202.90 a month. The Part D prescription drug benefit has been redesigned with a hard out-of-pocket cap. And a monthly payment plan for drug costs, while designed to help, can create billing surprises for anyone not watching their statements closely.

These aren’t hypothetical risks. The figures were confirmed by the Centers for Medicare & Medicaid Services in its official 2026 fact sheet. Those costs are locked in for the current year, but the patterns they reveal matter for the next Medicare Annual Enrollment Period, which runs from October 15 through December 7, 2026, and which is your chance to choose a plan for 2027. During that stretch, you can switch Medicare Advantage plans, move between Medicare Advantage and Original Medicare, or change your Part D prescription drug plan. With the enrollment period just months away, now is the time to understand which 2026 changes will likely shape what 2027 coverage looks like.

Change 1: Part B premiums and deductibles are both climbing

CMS confirmed that the standard monthly Part B premium for 2026 is $202.90, up from $185.00 in 2025. That $17.90 monthly increase adds up to $214.80 over the course of a year. The annual Part B deductible has also risen, from $257 to $283, an additional $26 you owe before Medicare’s standard cost-sharing on outpatient services kicks in.

Put those together and you’re looking at $2,717.80 in Part B premiums and deductible costs for 2026, roughly $240 more than last year, with no change in your health or your care. For retirees budgeting on Social Security and savings, that’s real money.

Higher-income beneficiaries face steeper bills. CMS applies income-related monthly adjustment amounts (IRMAA) based on your modified adjusted gross income from two years prior. If your 2024 tax return pushed you into a higher bracket, your monthly Part B premium could be well above the standard $202.90. The updated IRMAA brackets are published in the same CMS fact sheet.

One reason this increase catches people off guard: Part B premiums are typically deducted directly from Social Security checks. If you haven’t reviewed your statements since January, you may have already been paying the higher amount without realizing it. Logging into your my Social Security account can help you confirm what’s being deducted and adjust your budget for the rest of the year.

Change 2: The Part D out-of-pocket cap reshapes drug spending

Thanks to the Inflation Reduction Act, there is now a firm annual limit on what you can be required to pay out of pocket for covered Part D prescription drugs. The cap is $2,100 for 2026, up from the original $2,000 cap that took effect in 2025, and it will be adjusted annually based on growth in average per-capita Part D spending. The maximum Part D deductible has also risen to $615 for 2026 from $590 in 2025, though many plans set lower deductibles or none at all.

For people who take expensive brand-name drugs or multiple specialty medications, this ceiling is a significant safeguard. Before the IRA’s phased redesign, some beneficiaries faced thousands of dollars more in annual drug costs with no hard limit. The cap puts a firm floor under the worst-case scenario.

But the cap does not eliminate cost. It sets a maximum. If your medications are relatively inexpensive, you may never approach it, and your actual spending will depend on your plan’s formulary, tier structure, and copay or coinsurance rates. Plans can and do change which drugs they cover and what tier they assign them to each year. A medication that cost you a $10 copay last year could sit on a higher tier in 2026, raising your per-fill cost even though the overall cap is in place.

This is why your plan’s Annual Notice of Change matters so much. Plans are required to mail that document by September 30, and it will list every formulary change, tier reassignment, and cost-sharing shift for the coming year. If a drug you rely on has moved to a more expensive tier or been dropped from coverage entirely, the enrollment window is your chance to find a plan that still covers it at a price you can manage.

A related 2026 change worth knowing about: the first ten drugs selected for Medicare price negotiation under the Inflation Reduction Act now have negotiated prices in effect. CMS estimates that roughly 9 million enrollees who use these medications will save about $1.5 billion in out-of-pocket costs this year. The negotiated drugs are listed on Medicare.gov; if you take any of them, your plan’s cost-sharing for those medications may have changed at the start of the year.

Change 3: The new payment plan can create late-year billing surprises

Starting in 2025, all Part D plans are required to offer the Medicare Prescription Payment Plan. This option lets you spread your out-of-pocket drug costs into capped monthly installments rather than paying the full amount at the pharmacy counter each time you fill a prescription. CMS designed it to prevent the “January shock” that hits beneficiaries who face large deductibles and high-cost fills at the start of the year. The program continues into 2026, and if you enrolled at the beginning of this year, you are already seeing how the installments work in practice.

The concept is simple. Your plan estimates your total out-of-pocket drug costs for the year and divides them into roughly equal monthly payments. If your projected annual spending is $1,200, you would pay around $100 a month instead of potentially owing several hundred dollars in January and February when deductibles reset.

The catch is that payments are not locked in. They are recalculated whenever your prescriptions change. If your doctor adds a new medication in August, the plan recalculates your remaining projected costs and spreads them over the months left in the year. A $600 drug added in October could mean your monthly installment jumps sharply for the final two or three billing cycles. For someone already budgeting tightly, that late-year spike can feel like exactly the kind of surprise the payment plan was supposed to prevent.

This timing risk is especially relevant for people with conditions that flare seasonally, like respiratory illnesses that worsen in fall and winter, or for anyone whose treatment plan is adjusted after mid-year lab results. The payment plan smooths early-year costs but can concentrate spending into the fourth quarter, when many households are already stretched by heating bills, holiday expenses, and year-end medical appointments.

Before opting in (or staying enrolled), compare what you would pay month by month under the payment plan against what you would owe at the pharmacy counter under traditional cost-sharing. If your medication regimen is stable and unlikely to change, the payment plan may genuinely help with cash flow. If your prescriptions tend to shift during the year, paying as you go may give you a clearer picture of your costs in real time.

How Medicare Advantage plan shifts interact with these three cost changes

Medicare Advantage plans bundle Part A, Part B, and often Part D into a single plan, and they carry their own premium and benefit changes each year. In recent years, many Advantage plans have kept their listed premiums low or even at $0, but that headline number can obscure rising costs elsewhere. Plans may narrow provider networks, increase specialist copays, add prior authorization requirements, or shift prescription drug tiers in ways that directly amplify the three cost changes described above.

For example, if your Advantage plan’s embedded Part D coverage moves one of your medications to a higher tier for 2026, you could hit the out-of-pocket cap faster, but you will also pay more per fill along the way. If the plan tightens its network and your preferred doctor is no longer in-network, you may face out-of-network cost-sharing rates on top of the higher Part B deductible. And if you are using the Medicare Prescription Payment Plan through your Advantage plan’s drug benefit, the same late-year recalculation risks apply.

Your Advantage plan’s Annual Notice of Change, mailed by September 30, will detail every shift in premiums, copays, networks, and formularies for the coming year. Reviewing that document alongside the broader Part B and Part D changes discussed here is the clearest way to see the full picture of what 2026 will cost you. Use the Medicare Plan Finder on Medicare.gov to compare your current Advantage plan against alternatives in your area, entering your prescriptions, preferred pharmacies, and doctors for side-by-side cost estimates. One thing to know going in: the number of stand-alone Part D plans nationwide has decreased meaningfully in 2026, dropping from 464 to about 360, so even readers who have stayed with the same plan for years may find fewer comparable alternatives during the next AEP.

If your income is limited, check whether you qualify for the Extra Help program (also called the Low-Income Subsidy), which can significantly reduce Part D premiums, deductibles, and copays. Eligibility thresholds are updated annually, and some people who did not qualify in previous years may qualify now.

With Part B costs already higher in 2026, the Part D benefit restructured, and a payment plan that demands closer attention to billing cycles, this is not a fall to let your coverage auto-renew for 2027 without a second look at how this year’s changes are playing out. The enrollment window opens October 15 and closes December 7. The months between now and then are the time to prepare, so the choices you make during that period reflect what you actually need and what you can actually afford.